Sphingolipidomic Profile in Anorexia Nervosa

Recruiting

• Conditions: Anorexia Nervosa

• Registration Number: NCT06800937
• Lead Sponsor: Istituto Auxologico Italiano

Brief Summary

: The objective of this research project will be to determine the sphingolipidomic profile in a group of women (\> 18 years) affected by Anorexia Nervosa (AN), phenotypically characterized (restricting \[AN-R\] vs binge-eating purging \[AN-BP\]). Specific questionnaires will be administered for the definition of the severity of the eating disorder and depressive state (suicidality), to which will be added the evaluation of gonadal function (i.e., plasma levels of estradiol/progesterone and use of oral contraceptives).

Based on the specific lipidomic profile, which the present research project hopes to characterize, it will be possible to appropriately modify the diet of rehabilitation programs and, in the future, improve the effectiveness of the treatment itself, especially in the long term.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-19
• Status Verified: 2025-01
• Study First Submitted: 2025-01-24
• Study First Submitted QC: 2025-01-24
• Last Update Submitted: 2025-01-24
• Study First Posted: 2025-01-30
• Last Update Posted: 2025-01-30
• Primary Completion: 2026-06-30
• Study Completion: 2026-06-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Female sex
• Age: 18 years or older
• Diagnosis of Anorexia Nervosa in the acute phase
• Hospitalized at the Division of Eating and Nutrition Disorders (END), San Giuseppe Hospital, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy

Exclusion Criteria

• Absence of signed Informed Consent

Control group:

Inclusion Criteria:

• Female sex
• Age: 18 years or older
• BMI between 18.5 and 24.9 kg/m2

Exclusion Criteria:

• Absence of signed Informed Consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ceramides	Baseline	Plasma level of ceramide
Dihydroceramides	Baseline	Plasma level of dihydroceramides

Trial Locations

Locations (1)

Istituto Auxologico Italiano IRCCS, Site Piancavallo; 🇮🇹 Oggebbio, Verbania, Italy